Aurobindo receives FDA OK for generic Emflaza
Deflazacort Tablets are indicated for the treatment of Duchenne muscular dystrophy in patients 5 years of age and older.
Aurobindo has obtained approval from the Food and Drug Administration for Deflazacort Tablets, in dosage strengths of 6 mg, 18 mg, 30 mg and 36 mg.
Aurobindo Pharma’s Deflazacort Tablets are the generic of PTC Therapeutics’ Emflaza.
[Read more: Aurobindo gets FDA nod for 3 generics]
Deflazacort Tablets are indicated for the treatment of Duchenne muscular dystrophy in patients 5 years of age and older.